Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9163 posts found.

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024 Research and Development Bayer, Cardiology, cardio, cvd

Bayer and Evotec have announced that they have updated the focus of their collaboration to work on the development of …
News

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024 Research and Development Novartis, PeptiDream, Pharmacy, collaboration, drug discovery, peptides

PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.
News

Regeneron and Mammoth Biosciences announce CRISPR collaboration

April 26, 2024 Research and Development Pharmacy, Regeneron, crispr, gene editing

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration for the research, development and commercialisation of in vivo CRISPR-based gene …
News

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024 Research and Development Oncology, Ono Pharmaceutical, Prism BioLab, research and licensing agreement

Prism BioLab has announced that it has entered into a target-exclusive research and licensing agreement with Ono Pharmaceutical. Under the …
News

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024 Research and Development Cardiology, Sanofi, clinical trial, thrombocytopenia

Sanofi has announced positive results from its phase 3 LUNA 3 study, which assessed rilzabrutinib 400mg twice daily oral treatment …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024 Research and Development Kaerus Bioscience, Neurolentech, Neurology, neurodevelopmental disorders, neurology

Neurolentech has announced that it has entered into a technology access partnership with Kaerus Bioscience, with the aim of driving …
News

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024 Research and Development GSK, Reproductive health, clinical trial, gonorrhoea, sexual health

GSK has announced positive results from its phase 3 EAGLE-1 trial for gepotidacin, a potential first-in-class oral antibiotic for the …
News

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024 Research and Development Ear Nose & throat, Eli Lilly, clinical trial, sleep apnoea, tirzepatide

Eli Lilly has announced positive topline results from its SURMOUNT-OSA phase 3 trials which demonstrated that tizepatide injection (10mg or …
News

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024 Research and Development AbbVie, Immunology, Medincell, collaboration

Medincell and AbbVie have announced that they have entered into a collaboration to co-develop and commercialise up to six next-generation …
News

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024 Research and Development Intra-Cellular Therapies, Neurology, clinical trial, major depressive disorder, mental health

Intra-Cellular Therapies has announced positive topline results from Study 501, which assessed lumateperone 42mg as an adjunctive therapy to antidepressants …
News

Novartis shares new data about Fabhalta for IgAN treatment

April 16, 2024 Research and Development Fabhalta, IgAN, Nephrology, Novartis, nephropathy

Novartis has announced new results from a pre-specified interim analysis of its phase 3 APPLAUSE-IgAN trial of Fabhalta (iptacopan), an …
News

Genentech’s Columbi meets primary endpoint in phase 3 trial for lymphoma treatment

April 15, 2024 Research and Development Columbi, Genentech, Oncology, Roche, clinical trial, lymphoma

Genentech, part of the Roche Group, has announced that its phase 3 STARGLO trial has met its primary endpoint of …
News

Lipocine announces results from phase 2 trial for obesity drug

April 12, 2024 Research and Development Lipocine, Obesity, clinical trial, weight loss

Lipocine Inc has announced results from its phase 2 clinical trial (NCT04134091), which includes results for LPCN 2401, the company’s …
News

TILT Biotherapeutics shares data on TILT-123 with Keytruda for ovarian cancer treatment

April 10, 2024 Research and Development Merck, National Cancer Institute, Oncology, TILT Biotherapeutics, keytruda, ovarian cancer

TILT Biotherapeutics has announced promising preliminary safety and efficacy data from its ongoing phase 1 clinical trial (NCT05271318) in platinum …
News

FDA clears Oryzon’s phase 1/2 trial for lung cancer treatment

April 10, 2024 Research and Development FDA, Oncology, Oryzon, lung cancer

Oryzon Genomics has announced that the US Food and Drug Administration (FDA) has approved its investigational new drug (IND) application …
News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024